Background. Cardiac hypertrophy results in an increased deposition of the extracellular matrix (ECM) proteins fibronectin and collagen. Recent evidence indicates that angiotensin II (Ang II) might have an important role in the development of myocardial fibrosis accompanying cardiac hypertrophy. We sought to determine whether fibroblasts of cardiac origin (isolated from neonatal and adult animals) express
M yocardial fibrosis is a pathological entity that is frequently associated with the development of cardiac hypertrophy. Indirect in vivo evidence regarding the potential trophic role of angiotensin II (Ang II) in the development of cardiac hypertrophy and interstitial fibrosis has been accumulating in the literature. These studies indicate that both left ventricular hypertrophy and the actual fibrosis may be reversed through the administration of angiotensinconverting enzyme (ACE) inhibitors (for reviews see References 1 through 4). It was recently demonstrated that even low doses of ACE inhibitors can attenuate the development of left ventricular hypertrophy in the abdominally banded rat model.5 Increased ACE activity also has been found in the hypertrophied left ventricle and has been associated with altered diastolic properties.6,7 Over the past decade, a large amount of evidence has accumulated regarding the presence of local, independent renin-angiotensin systems in tissues of diverse disposition and abundance of these fibers have been shown to change with cardiac hypertrophy.25 Two thirds of the myocardial cell population is composed of nonmyocyte cells, the great majority of which are fibroblasts. 26 These cells are responsible for the production and deposition of the extracellular matrix proteins fibronectin and cardiac collagens types I and III. 1, 25 Fibronectin is an extracellular matrix and plasma protein with various functions that plays important roles in cell adhesion and migration. 27 Functional roles for this molecule have been postulated during processes such as embryogenesis, wound healing, and organogenesis in the heart.27-30 It is possible that this protein molecule might play an important role in the remodeling of the cardiac interstitium observed secondary to myocardial hypertrophy.31,32 Although indirect evidence is supportive of a role for Ang II in regulating extracellular matrix deposition in the myocardium, nothing is known about the ability of Ang II to exert trophic effects on cardiac fibroblasts. In cultured cardiac fibroblasts, complicating systemic effects are absent and direct Ang II effects can be clearly determined. Thus, the objectives of the current study were (1) to determine whether cultured neonatal and adult rat cardiac fibroblasts express receptors for Ang II and to examine their subtype, affinity, abundance, and uniformity of distribution; (2) to examine the expression of mRNA for the AT, Ang II receptor on both types of fibroblasts and compare their level of expression with those of cardiac myocytes; and (3) to evaluate changes in mRNA levels for the extracellular matrix proteins fibronectin and collagen types I and III and to examine for changes in total collagen deposition in cultured adult cardiac fibroblasts after stimulation with Ang II.
Methods

Cell Culture
Cardiac fibroblasts from newborn (1-to 2-day-old) Sprague-Dawley rats were isolated by use of a modification of a previously described protocol used in this laboratory for the preparation of neonatal myocytes. 33 Briefly, 40 to 50 neonatal hearts were rapidly excised from anesthetized animals, minced, and placed in a collagenase/pancreatin digestion solution. After four to five digestion periods, the accumulated cell suspension was submitted to a Percoll (Pharmacia LKB, Uppsala, Sweden) gradient centrifugation step that separated myocyte and nonmyocyte cell types into two distinct bands. The nonmyocyte cell band (mostly fibroblasts) was resuspended in Dulbecco's modified Eagle's medium (DMEM) supplemented with antibiotics (penicillin/streptomycin/Fungizone; Gibco BRL, Grand Island, NY) plus 10% fetal bovine serum (FBS) . Cardiac 
Immunocytochemistry
Immunocytochemical staining (as described below) was used to evaluate the extent of cell purity achieved in our cell culture preparations. Monoclonal antibodies directed against sarcomeric (striated muscle) actin (Sigma Chemical Co, St Louis, Mo) and desmin (Amersham Corp, Arlington Heights, Ill) were used to positively identify cardiac myocytes and smooth muscle cells, whereas a polyclonal antibody directed against human factor VIII was used for endothelial cells (Dako Corp, Carpinteria, Calif). Positive staining with a polyclonal anti-vimentin antibody (Polysciences Inc, Warrington, Pa) and negative for the above-mentioned factors characterized cardiac fibroblasts.
A Streptavidin alkaline phosphatase-based protocol35 with Vector Red (Vector Laboratories, Burlingame, Calif) as a chromogen was used for immunocytochemical staining of our cell culture preparations. This method enhances the effects of immunostaining by yielding a red reaction that is also visible under fluorescent microscopy with rhodamine and fluorescein lights. Cells were initially fixed in a 1:1 mixture of cold acetone and methanol at 4°C for 15 minutes and allowed to dry. Blocking was performed with 10% serum (from the animal source of the secondary antibody to be used) in 0.1% bovine serum albumin/Tris-buffered saline (BSA/ TBS) and was followed by a second blocking step using human type AB serum. Primary antibodies were subsequently added and incubated for 60 minutes at room temperature. Preimmune sera of the animal species in which the primary antibody was developed were used as negative controls. Biotinylated IgGs were used as the secondary antibody, and incubation was carried out for 60 minutes. This step was followed by incubation with alkaline phosphatase-conjugated Streptavidin for 30 minutes. An Coated chamber slides were exposed for 3 weeks at -20°C. Slides were developed (Kodak, Dektol), fixed, dried, and, after addition of a coverslip, observed with both bright-and dark-field microscopy. Autoradiographic data were quantified with an image analysis system. Background silver grain density was counted from a field devoid of cell structures and subtracted from the total count. Five different fields from each chamber slide were selected at random, and an average number (mean±SD) was computed from the grain counts.
RNA Extraction
Total cellular RNA was extracted from 100-mm cell culture dishes according to a modified procedure of Chomczynski and Sacchi.38 Culture dishes were placed on ice, and cell layers were washed twice with 1 x PBS. A 4 mol/L solution of guanidine isothiocyanate was added to the plate, and the cell suspension was lysed and collected through scraping. A phenol/chloroform extraction was performed, and the aqueous phase was transferred to a new tube after centrifugation at 10 000g at 4°C for 20 minutes. Total RNA was precipitated through two consecutive ethanol precipitations separated by an additional phenol/chloroform extraction step. Final RNA yield was quantified by UV spectrophotometry at 260 nm.
Northern Blots
For Northern blot studies, 5 to 20 ,ug total RNA was electrophoresed on 1% agarose gels and subsequently processed according to an established protocol. 39 Receptor Autoradiography Neonatal and adult cardiac fibroblasts cultured in four-well chamber slides demonstrated an appreciable number of specific Ang II binding sites that were uniformly distributed over the fibroblast population and not confined to a subgroup of cells (Fig 5) . As (Fig 7) . Treatment with Ang II also resulted in a fourfold induction of GAPD levels (data not shown). No differences were detected in cell counts performed on subconfluent neonatal and adult fibroblasts grown in serum-free conditions before and after 24, 48, 55 Sechi et a155 reported that adult rat myocardial tissue expresses both subtypes of the Ang II receptor in about equal numbers, with higher levels of both types of Ang II receptors present immediately after birth. However, published data from several groups suggest that AT2 receptor subtypes can downregulate in different tissues early after birth and that when cells are maintained in culture, the AT2 receptor is also sensitive to passage number.5054 Since the isolated neonatal fibroblasts in our study were from 1-to 2-day-old rats, it is possible that a similar pattern of downregulation occurred, leading to a failure to observe any AT2 receptors. No current study has been able to establish the cell source of AT2 binding in the heart, and this subject awaits further investigation.
An autoradiographic binding approach was also used in this study to confirm the results obtained from our competition experiments and to examine whether the expression of the receptors was uniformly distributed or confined to a subpopulation of cells. This was an important part of the study, given that binding results could potentially have been generated from contamination originating from other cell types, most importantly endothelial and smooth muscle cells. As illustrated by the autoradiography results, the expression of the receptors was not confined to a subpopulation of cells but rather was evenly distributed over the entire cell population. The possibility of contamination of our cardiac fibroblast cultures by other cell types was further corroborated by results from immunohistochemical staining using antibodies directed against sarcomeric actin and desmin for identification of cardiac myocytes, desmin for smooth muscle cells, factor VIII for endothelial cells, and vimentin for all four cell types (including cardiac fibroblasts). Staining results from cells at passage 1 or greater were positive only for vimentin. This pattern of staining has been widely accepted as a method for characterizing cardiac fibroblasts in culture. 34 postulate that some of the hypertrophic and fibrotic effects of Ang II could be mediated by release of growth factors such as TGF-j3 from the myocardial interstitial cell population, suggesting that these cells might serve a paracrine function within the myocardium. We also determined in this study whether Ang II can increase formation of extracellular matrix proteins. A hydroxyproline assay was used to quantify collagen levels. We observed a significant increase in total collagen deposition, indicating that under the conditions tested, Ang II exerts a stimulatory effect over adult cardiac fibroblast extracellular matrix production. Results obtained from gene expression (mRNA) experiments would suggest that most of the collagen deposited would be type III. However, this matter requires further investigation to determine whether enhanced collagen deposition results from increased expression of mRNAs and/or altered degrees of collagen turnover.
Myocardial fibrosis is a pathological finding that is frequently associated with the development of cardiac hypertrophy. Common histological findings include different degrees of perivascular and interstitial fibrosis. These changes, in conjunction with alterations at the level of the myofibers, are frequently referred to as myocardial remodeling.1"4 Several lines of evidence strongly suggest that Ang II might play a very active role in regulating the development of cardiac fibrosis. These include, among others, experimental studies in which Ang II has been infused into animals, renovascular hypertension has been artificially induced, or myocardial remodeling has been prevented through the use of ACE inhibitors.4 However, most of these experimental models are incapable of truly discriminating the capacity of Ang II to act as a regulator of fibroblast growth and function in an environment free of any systemic effects. Our study design used isolated, cultured cardiac fibroblasts. The capacity of Ang II to stimulate cardiac fibroblast function in our experiments was independent of any complicating systemic effects such as increase in cardiac workload, inotropic mechanisms, or tissue metabolism. The results from this study lend basic experimental support to the contention that either ACE inhibitors or specific Ang II receptor antagonists might be beneficial in patients who are at high risk of developing substantial and most likely harmful degrees of myocardial remodeling and fibrosis.
